print back
Bioindustry Park Silvano Fumero S.p.A.

Bioindustry Park, a science park with bioindustrial and biotechnological aims, promotes and supports research in the field of Life Sciences. The Park acts as a link between university research and the corporate world, which is intended to stimulate the foundation and growth of innovative companies. In addition, the Park offers possibilities for branch offices, research laboratories and special consulting, such as firm check-ups, feasibility studies and technology transfer

Do you want to print an overview or a detailed profile?

Adress

Via Ribes, 5
10015 Colleretto Giacosa - Turin
(Piedmont)

Telephone

+39 0125 561311

Fax

+39 0125 538350

World Wide Web

www.bioindustrypark.eu

 


Technology transfer

Inclusion in EU project

  • IRC: cooperation EEN Alps
  • BIO-CT: the company and those responsible for the technology transfer offer the opportunity of getting rapidly and economically efficiently industrial Proof of Concept (I-PoC); thus the research results are economically correctly valorised (scientific Proof of Concept or S-PoC). The development of the initial phase (early stage) is seen worldwide as the weak point in the innovation chain.
  • TRANSALPINE BIOCLUSTER: the aim of the project is the creation of a cluster network in the biotech and meditech spheres involving six European regions. Thereby companies should be facilitated in the Transalpine area to be responsive to the chance of increasing their innovative ability. The activity contains the formation of two thematic pilot networks (“Autonomy and Healthcare” and “New Diagnosis and Therapies“), which can be self-supporting in the long term.
  • BIOCULTURE: By means of the project, the competitiveness of small and medium-sized companies in the Life Science segment should be strengthened in which resources of international corporate culture are produced, developed and made available.
  • NETBIOCLUE: The project analysed the evolution of 14 European Biotech Clusters with the aim of determining the success factors and the best practices of recent years. In networking and the exchange, pilot projects and important proposals for the regional, national and European policy with regard to the development of branch-related clusters were drafted.
  • PASSPORT: In the project, what was concentrated on was strengthening the competitiveness of the Life Science companies by means of a stronger participation in research programmes, above all in the VII. Framework Programme. In addition, incentives for networking between the companies and the promotion of cross-border corporate cooperation were set up.

Activities

  • Tesina – Technology Scouting in Academia The aim of the project is to support the research with a system, which implements the newly developed ideas and results more simply into practice. These inventions, which were achieved as part of the experimental research into innovations, should be of great benefit to the regional companies in the future.
  • iTech-Plat is an initiative of the Bioindustry Park, which is financed by the Piedmont Region. The aims are the valorisation of the scientific results from the Life Science sector applied to health. In this segment, it is extraordinarily important to identify both successful research areas and to provide resources and knowledge in order to pass on results obtained and patents to companies, which produce new pharmaceuticals and diagnoses for the final market. The well being of all is here the focus of attention. Involved in iTech-Plat are predominantly young researchers and small, innovative start up companies. With this project, a process has been set in motion, which, with the help of selection, development and valorisation (also at international level), initiated 15 research projects in various segments of molecular diagnostics via pharmacogenomics and bioinformatics through to nano-biotechnology. The projects have led to date to six patent applications.
  • Discovery, a Canavese Park bioindustry project, supports Italian researchers with the foundation of a company on the basis of their research results in the Life Science Sector. To date have emerged more than 15 new companies with a total investment volume of over 7 Mio. Euros. Based on the following three factors, the Discovery model is one of the most significant of the park: 1) selection of projects with investment value, 2) support of the bioincubator by the public institution, the Piedmont Region and 3) –for Italy novel modalities – provision of capital by private, non-institutional investors, above all Eporgen Venture.

Contacts to german companies already exist:

  • Technology foundation Innovationszentrum Berlin GmbH - BioTop (DE) – in cooperation with BIO-CT
  • Helmholtz-Zentrum München - German Research Center for Environmental Health (DE) – in cooperation with ALPS BIO CLUSTER
  • Alsace Biovalley (FR-DE-SW): in cooperation with ABC Europe
  • Weihenstephan University of Applied Sciences, Faculty of Biotech. and Bioinformatics (DE) – in cooperation with ALPS BIO CLUSTER
  • BioM – Biotech Cluster Development Gmbh – support of Polo innovazione
  • Steinbeis Research Center (Rostock, DE): in cooperation with BioProtech
  • Technologiepark Heidelberg GmbH – support of Polo Innovazione